Matches in Nanopublications for { ?s ?p "[The validation of KRAS mutations as a negative marker of response to anti-epidermal growth factor receptor (EGFR) antibodies has meant a seminal advance towards treatment individualisation of colorectal cancer (CRC) patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 2 of
2
with 100 items per page.
- NP800410.RAXI6GU23cwOfsdrC288UjVUCCK71d_7Xgl9j_mtn34uo130_assertion description "[The validation of KRAS mutations as a negative marker of response to anti-epidermal growth factor receptor (EGFR) antibodies has meant a seminal advance towards treatment individualisation of colorectal cancer (CRC) patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP800410.RAXI6GU23cwOfsdrC288UjVUCCK71d_7Xgl9j_mtn34uo130_provenance.
- NP800408.RACbD34BVeXcE2NMco8m9AW7aTgLuGyYR4XDi3myrl8Yo130_assertion description "[The validation of KRAS mutations as a negative marker of response to anti-epidermal growth factor receptor (EGFR) antibodies has meant a seminal advance towards treatment individualisation of colorectal cancer (CRC) patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP800408.RACbD34BVeXcE2NMco8m9AW7aTgLuGyYR4XDi3myrl8Yo130_provenance.